Novavax
Focus: Novavax is a biotechnology company specializing in virus-like particle (VLP) and micelle-based vaccines focused on infectious diseases and respiratory indications. The company is headquartered in Gaithersburg, Maryland and operates at mid-cap biotech scale.
Profile data last refreshed 32m ago · AI intelligence enriched 2w ago
Open Jobs
0
About Novavax
AI assessmentNot HiringNo open roles listed right now. Follow Novavax to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
13 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Novavax COVID-19 Vaccine
Declining
Peak
Commercialized protein subunit vaccine in Phase 4 with multiple variant formulations; primary current revenue driver but facing declining pandemic demand.
Pipeline & Clinical Trials
Help build intelligence for Novavax
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.